Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-006310
Filing Date
2025-01-16
Accepted
2025-01-16 18:31:40
Documents
1
Period of Report
2025-01-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5766
  Complete submission text file 0000950170-25-006310.txt   7194
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address
Bressi Jerome Charles (Reporting) CIK: 0002034505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 25536645